2017
DOI: 10.1016/s0140-6736(16)31713-5
|View full text |Cite
|
Sign up to set email alerts
|

Dilated cardiomyopathy

Abstract: Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and nuclear envelope proteins, among others, account for up to 35% of cases. Acquired causes include myocarditis and exposure to alcohol, drugs and toxins, and metabolic and endocrine disturbances. The most common presenting symptoms relate to congestive heart failure, but can also include circulatory collapse, arrhythmias, and thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
466
0
11

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 497 publications
(514 citation statements)
references
References 165 publications
1
466
0
11
Order By: Relevance
“…The first human mutation identified was R9C (PLN R9C ), located in domain Ia of the regulatory region[20]. This autosomal dominant, missense mutation at nucleotide 25 causes the typical DCM phenotype, with a severe dilation of the left ventricle and decreased contractile function of the heart muscle[21]. The later sequencing of R9H and R9L mutations in DCM patients further emphasized the importance of PLN’s position 9 for SERCA regulation [22].…”
Section: Introductionmentioning
confidence: 99%
“…The first human mutation identified was R9C (PLN R9C ), located in domain Ia of the regulatory region[20]. This autosomal dominant, missense mutation at nucleotide 25 causes the typical DCM phenotype, with a severe dilation of the left ventricle and decreased contractile function of the heart muscle[21]. The later sequencing of R9H and R9L mutations in DCM patients further emphasized the importance of PLN’s position 9 for SERCA regulation [22].…”
Section: Introductionmentioning
confidence: 99%
“…Here, two scenarios can be thought of cases with a cardiomyopathy diagnosis preceding death and cases with a sudden cardiac death (ie, no lifetime cardiomyopathy diagnosis). Dilated cardiomyopathy in live patients can be indicated by rather unspecific symptoms, such as abdominal pain, fatigue or nausea, but formal diagnosis gets only confirmed via echocardiography, MRI and/or histological analyses 20. For individuals who died from a sudden cardiac death, an analogue diagnostic workup may not be feasible.…”
Section: Discussionmentioning
confidence: 99%
“…The typical symptoms of DCM include cardiac dilation, systolic dysfunction, and, in particular, left ventricular enlargement or dilatation [McNally and Mestroni, 2017;Weintraub et al, 2017]. According to the Olmsted County studies, the prevalence of DCM is likely to be 1 in 250 individuals [Codd et al, 1989;Hershberger et al, 2013].…”
Section: © 2019 S Karger Ag Baselmentioning
confidence: 99%